AI Article Synopsis

  • Hypoxia-adapted cancer cells play a critical role in cancer progression, prompting research to find molecules that target these cells.
  • The marine compound furospinosulin-1 has shown selective growth inhibition on hypoxic cancer cells and has demonstrated anti-tumor effects in live models.
  • This study reveals that furospinosulin-1 effectively targets hypoxic tumor areas by binding to transcriptional regulators p54(nrb) and LEDGF/p75, which are newly identified players in hypoxia adaptation.

Article Abstract

Hypoxia-adapted cancer cells in tumors contribute to the pathological progression of cancer. Cancer research has therefore focused on the identification of molecules responsible for hypoxia adaptation in cancer cells, as well as the development of new compounds with action against hypoxia-adapted cancer cells. The marine natural product furospinosulin-1 (1) has displayed hypoxia-selective growth inhibition against cultured cancer cells, and has shown in vivo anti-tumor activity, although its precise mode of action and molecular targets remain unclear. In this study, we found that 1 is selectively effective against hypoxic regions of tumors, and that it directly binds to the transcriptional regulators p54(nrb) and LEDGF/p75, which have not been previously identified as mediators of hypoxia adaptation in cancer cells.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbic.201500519DOI Listing

Publication Analysis

Top Keywords

cancer cells
24
hypoxia-adapted cancer
12
cancer
8
transcriptional regulators
8
regulators p54nrb
8
p54nrb ledgf/p75
8
hypoxia adaptation
8
adaptation cancer
8
cells
6
furospinosulin-1 marine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!